Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications.
Dopamine receptor activation can lead to pronounced changes in cardiovascular function. The myriad of effects produced by dopamine receptor agonists results from the activation of dopamine receptors located at different anatomical sites in the cardiovascular system. Further basic research is required to better characterize these dopamine receptors so as to allow the development of more specific dopamine receptor agonists. Endogenous dopamine may be involved in the physiological control of fluid and electrolyte balance and continuing research efforts in this area should provide for a better understanding of the role of cardiovascular dopamine receptors in the maintenance of overall circulatory homeostasis. Cardiovascular dopamine receptor stimulation represents an important and promising approach for the development of novel therapeutic agents for the treatment of hypertension, angina pectoris, congestive heart failure and acute renal failure.
D058186:Acute Kidney Injury / Q000628:therapy; D000787:Angina Pectoris / Q000628:therapy; D000818:Animals; D002320:Cardiovascular Physiological Phenomena; D002319:Cardiovascular System / Q000294:innervation; D002490:Central Nervous System / Q000502:physiology; D004298:Dopamine / Q000502:physiology; D018492:Dopamine Antagonists; D005728:Ganglia, Sympathetic / Q000502:physiology; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000628:therapy; D007668:Kidney / Q000294:innervation / Q000502:physiology; D011954:Receptors, Dopamine / Q000502:physiology*; D013569:Synapses / Q000502:physiology
D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D004298:Dopamine